Inhibition of extracellular signal-regulated kinase activity by sorafenib increases sensitivity to DNR in K562 cells. [electronic resource]
Producer: 20140305Description: 1895-901 p. digitalISSN:- 1791-2431
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Butadienes -- pharmacology
- Cell Line, Tumor
- Cell Proliferation
- Daunorubicin -- administration & dosage
- Drug Synergism
- Extracellular Signal-Regulated MAP Kinases -- antagonists & inhibitors
- Humans
- K562 Cells
- MAP Kinase Signaling System -- drug effects
- Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- Niacinamide -- administration & dosage
- Nitriles -- pharmacology
- Phenylurea Compounds -- administration & dosage
- Phosphorylation -- drug effects
- Signal Transduction -- drug effects
- Sorafenib
- U937 Cells
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.